Name: Compass Therapeutics, Inc. (CMPX) Balance Sheet
Creator: FinSpry

Compass Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Compass Therapeutics, Inc. (CMPX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	43.48	24.23	34.95	144.51	47.08
Short-Term Investments	83.24	128.23	151.66	0.00	0.00
Cash & Short-Term Investments	126.72	152.46	186.61	144.51	47.08
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	6.03	1.42	8.18	2.59	3.13
Total Current Assets	132.75	153.88	194.79	147.11	50.20
Non-Current Assets
Property, Plant & Equipment (Net)	7.08	2.67	4.53	6.33	1.13
Other Non-Current Assets	0.57	0.32	0.32	0.32	0.58
Total Non-Current Assets	7.65	2.99	4.85	6.65	1.71
Total Assets	140.40	156.88	199.65	153.76	51.91
Current Liabilities
Accounts Payable	2.25	4.09	3.38	0.87	2.63
Short-Term Debt	0.34	0.00	0.00	0.00	7.47
Current Portion of Long-Term Debt	0.00	0.00	0.00	0.00	7.47
Accrued Liabilities	3.49	2.51	10.13	7.17	1.57
Other Current Liabilities	6.29	0.00	0.00	0.00	0.00
Total Current Liabilities	8.87	7.80	16.17	10.63	10.10
Non-Current Liabilities
Long-Term Debt	6.30	0.54	1.84	3.05	1.87
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	6.30	0.54	1.84	3.05	1.87
Total Liabilities	15.17	8.34	18.01	13.68	11.97
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-364.68	-315.31	-272.81	-233.59	-151.41
Accumulated Other Comprehensive Income	0.21	0.04	-0.30	0.00	0.00
Additional Paid-in Capital	489.69	463.80	454.74	373.66	191.35
Shares Outstanding	137.82	127.67	126.30	100.83	0.00
Total Stockholders' Equity	125.23	148.54	181.64	140.08	39.95
Total Liabilities & Equity	140.40	156.88	199.65	153.76	51.91